Pharmalink Consulting appoints five consultants
pharmafile | February 25, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Pharmalink Consulting
Regulatory affairs firm Pharmalink Consulting has announced the appointment and promotion of five consultants at their offices in the UK, US and India.
Stephen Loughrey, chief executive of the company said: “We are delighted to welcome on board some of the most respected names in the business while, at the same time, announcing the promotions of our own home grown talent.”
Key appointments and promotions include:
- Kevin O’Toole has been promoted to associate director – Commercial Operations. O’Toole has worked with Pharmalink for seven years and has been instrumental in driving growth across all healthcare sectors.
- Andrew Campbell will assume the newly developed role of senior director, Business Development. With previous experience at Fortune 500 companies Campbell will focus on growing the Pharmalink’s North American business and will report directly to Loughrey.
- Lucy Quinlan has also been at Pharmalink for seven years and has been promoted to the role of associate director, Resourcing and Recruitment. She will be responsible for the recruitment of all permanent employees and the long-term strategy for company-wide resourcing and recruitment.
- Emily Hawkins (pictured) joined the Pharmalink team at the end of last year as European Recruitment resourcer. From the US, Hawkins has a background in recruitment, and her appointment reflects the growing need for sourcing and recruiting the best consultants in the healthcare Regulatory Affairs arena.
- Vrushali Tambe has recently joined the Pharmalink Mumbai office as a Regulatory Affairs officer. Tambe was previously at GSK and completed her M.Sc. from Goa University.
Related Content
No items found
